Serological and molecular expression of Hepatitis B infection in patients with chronic Hepatitis C from Tunisia, North Africa

Laboratory of Clinical Virology, Institut Pasteur, Tunis, Tunisia.
Virology Journal (Impact Factor: 2.18). 09/2010; 7(1):229. DOI: 10.1186/1743-422X-7-229
Source: PubMed


This study reports the prevalence and the viral aspects of HBV infection in HCV-positive patients from Tunisia, a country with intermediate and low endemicity for hepatitis B and C, respectively.
HBV infection was assessed in the serum samples of 361 HCV-positive patients and compared to a group of HCV negative individuals. Serological markers were determined by ELISA tests and HBV DNA by real-time PCR. HBV serological markers were found in 43% and 44% of patients and controls, respectively. However, the serological and molecular expression of HBV infection differed in the two groups: The group of patients included more individuals with ongoing HBV infection, as defined by the presence of detectable HBsAg and or HBV DNA (17% and 12%, respectively). Furthermore, while most of the controls with ongoing HBV infection expressed HBsAg, the majority of HCV and HBV positive patients were HBsAg negative and HBV DNA positive. Genotyping of HCV isolates showed large predominance of subtype 1b as previously reported in Tunisia. Comparison of the replicative status of the two viruses found low HBV viral load in all co-infected patients as compared to patients with single HBV infection. In contrast, high levels of HCV viremia levels were observed in most of cases with no difference between the group of co-infected patients and the group with single HCV infection.
This study adds to the knowledge on the prevalence and the virological presentation of HCV/HBV dual infection, providing data from the North African region. It shows that, given the local epidemiology of the two viruses, co-infected patients are likely to have low replication levels of HBV suggesting a suppressive effect of HCV on HBV. In contrast, high replication levels for HCV were fond in most cases which indicate that the presence of circulating HBV-DNA does not necessarily influence HCV replication.

Download full-text


Available from: Imed Cheikh, Oct 09, 2014
  • Source
    • "Our research shows a very low prevalence (two cases among 23 578 personts tested) of hepatitis co-infection comparing with Tunisia (5%) and Egypt (22.5%) [28,29], these results indicate that the HBV positive patients investigated herein do not have an increased risk of exposure to HCV infection. Although this small sample size of reactive cases does not allow data to be compared with other reports, one Italian study found that rates of dual infection increased with age, and was more common in patients over 50 years of age [30]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background Viral hepatitis is a serious public health problem affecting billions of people globally. Limited information is available on this issue in Morocco. This cross-sectional study was undertaken with the aim of determining the seroprevalence and risk factors of hepatitis B virus (HBV) and hepatitis C virus (HCV) among the general population and among blood donors. Methods Blood samples from volunteers, have been screened with ELISA tests for detecting the hepatitis-B surface antigen (HBsAg) and anti-HCV. Within the seroreactive patients for HCV in the general population, RT-PCR was performed by the Cobas Ampliprep/Cobas Amplicor. Results HCV and HBV-seropositivity was documented in 1.58% and 1.81% out of 41269 and 23578 participants respectively from the general population. Two patients were found to be co-infected. HCV-RNA was detected by PCR in 70.9% of the 195 anti-HCV positive subjects. The anti-HCV prevalence was not different among males and females (P = 0.3). It increased with age; the highest prevalence was observed among subjects with >50 years old (3.12%). Various risk factors for acquiring HCV infection were identified; age, dental treatment, use of glass syringes and surgical history. In addition to these factors, gender and sexual risk behaviors were found to be associated with higher prevalence of hepatitis B. The HBV positivity was significantly higher among males than females participants in all age groups (P < 0.01). The peak was noticed among males aged 30–49 years (2.4%). None of the 152 persons younger than 20 years had HBsAg or anti-HCV. The prevalence of anti-HCV and HBsAg among 169605 blood donors was 0.62% and 0.96% respectively. Conclusions Our study provided much important information concerning hepatitis B and C prevalence and risk factors; it confirmed the intermediate endemicity for HCV infection and pointed to a decreasing trend of HBV incidence, which might reclassify Morocco in low HBV endemicity area. This could be attributed primarily to the universal HBV vaccination among infants and healthcare workers over the past 13 years. HCV and HBV infections in the present survey were mainly associated with nosocomial exposures. Prevention and control of HBV infection are needed to reduce HBV transmission between adults.
    Full-text · Article · Jan 2013 · BMC Public Health
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In Colombian blood banks, screening for the surface antigen of hepatitis B is mandatory in all units collected. Testing of antibody against core antigens is not administered, although this method may be useful to detect donors infected with the hepatitis B virus. The prevalence of occult hepatitis B was determined by applying a full-serological profile of hepatitis B virus to blood samples of blood donors. Between April 2008 and October 2009, a prospective cross sectional study was conducted using 628 samples from donors to blood banks located in four Colombian cities. Prevalence for hepatitis B had been previously recorded for these cities. Serological screening was performed for the complete virus; then nucleic acid amplification was tested in sera that were anti-HBc reactive and with a titer of anti-HBs ≤30 mUI/ml. Of the 628 samples tested, 129 met the serological criteria established to be tested nucleic acid amplification. None of them demonstrated evidence of nucleic acid amplification of hepatitis B virus. This is the first study in Colombia to detect the presence of blood donors that may be occult hepatitis B carriers. None was detected.
    Full-text · Article · Dec 2011 · Biomédica: revista del Instituto Nacional de Salud
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective: To estimate the rate of occult hepatitis B virus (HBV) among patients with chronic liver disease (CLD). Methods: After an informed consent, sera samples were collected during wApitrhi l 2004 to April 2005 from 280 patients (200 male and 80 female). They were previously diagnosed were CfiLrDst bscarseeedn oend hfoirs tory and ultrasound and were investigated for occult HBV infection. Sera anti- HBsAg and those which showed negative were tested for anti-HBc. The whichH iBnc t uprons iwtievree sseurbaj ewcetered ftuor ther tested for anti-HBs to identify sera with isolated anti-HBc infection. HBV-DNA testing using PCR to determine the rate of occult HBV Moreover, sera with occult HBV were tested for Anti-HCV and HCV-RNA using RT- PdCetRe.c tRede siunl ts: HBsAg was detected in 44 of 280 (15.7%). Of 236 HBsAg negative sera anti-HBc was was detected2 2i n(9 .3%). All anti-HBc positive sera were found to be anti-HBs negative. HBV-DNA sera. 11 of 22 (50.0%) sera with isolated anti-HBc indicating occult HBV in 4.3% of all infectNioonn ed ooef st heex isset raam wointhg occult HBV had anti-HCV or HCV- RNA. Conclusions: Occult HBV further investigation.
    No preview · Article · Feb 2012 · Asian Pacific Journal of Tropical Disease
Show more